Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder

NCT00457899 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

234

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to poor recruitment

Conditions

Schizophrenia
Schizoaffective Disorders
Psychotic Disorders

Interventions

DRUG: Quetiapine IR (Immediate Release)

Sponsor

AstraZeneca